Amgen Builds Up Future Launches As Oncology Biosimilars Slide

Firm Looks To Amjevita, Along With Stelara And Eylea Rivals, For Future Growth

 
• By Dave Wallace
  
Wooden businessman down up stairs
As Amgen’s oncology biosimilars decline, a lift will come from new products • Source: Shutterstock

More from Biosimilars

More from Products